You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 590 Anti-CD33 actinium-225 targeted radioimmunotherapy enhances the biologic activity of anti-CD47 antibody immunotherapy in preclinical models of acute myeloid leukemia

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
590 Anti-CD33 actinium-225 targeted radioimmunotherapy enhances the biologic activity of anti-CD47 antibody immunotherapy in preclinical models of acute myeloid leukemia
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021334026
Dec 20219605
Jan 20226405
Feb 20225208
Mar 202217806
Apr 20227009
May 202236010
Jun 202232011
Jul 20223607
Aug 20221803
Sep 20221609
Oct 20222608
Nov 20222207
Dec 20221403
Jan 2023203
Feb 20231601
Mar 20231803
Apr 20233006
May 20232204
Jun 2023202
Jul 202324013
Aug 20231405
Sep 20231804
Oct 20231605
Nov 202334013
Dec 20232603
Jan 20242601
Feb 20241804
Mar 20243803
Apr 20243203
May 20241806
Jun 20241001
Jul 20242404
Aug 20241005
Sep 20241401
Oct 20241407
Nov 2024801
Total14280215